Emil Kakkis
Founder bij ULTRAGENYX PHARMACEUTICAL INC.
Vermogen: 132 M $ op 31-03-2024
Profiel
Emil D. Kakkis richtte Ultragenyx Pharmaceutical, Inc. en Everylife Foundation for Rare Diseases op. Dr. Kakkis bekleedt de functie van President, Chief Executive Officer & Director bij Ultragenyx Pharmaceutical, Inc. Dr. Kakkis zit ook in de raad van bestuur van Emil Kakkis & Jenny Soriano Living Trust en Odylia Therapeutics en is voorzitter van Everylife Foundation for Rare Diseases. In zijn vorige carrière was Dr. Kakkis Chief Medical Officer & Senior Vice President voor BioMarin Pharmaceutical, Inc. en assistent professor aan het Harbor-UCLA Medical Center. Dr. Kakkis behaalde een doctoraat aan het Pomona College en een doctoraat aan de David Geffen School of Medicine.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-03-2024 | 2 827 898 ( 3.43% ) | 132 M $ | 31-03-2024 |
Actieve functies van Emil Kakkis
| Bedrijven | Functie | Begin |
|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Founder | 22-04-2010 |
| Emil Kakkis & Jenny Soriano Living Trust | Director/Board Member | - |
Everylife Foundation for Rare Diseases
 Everylife Foundation for Rare Diseases Miscellaneous Commercial ServicesCommercial Services EveryLife Foundation for Rare Diseases is a non-profit organization that aims to advance the development of treatment and diagnostic opportunities for rare disease patients through science-driven public policy. The non-profit company is based in Novato, CA and was founded by Emil D. Kakkis. The foundation provides training, education, resources, and opportunities to make patient voices heard, with the belief that activating the patient advocate can change public policy and save lives. | Founder | 01-03-2009 |
| Odylia Therapeutics | Director/Board Member | 01-01-2019 |
Eerdere bekende functies van Emil Kakkis
| Bedrijven | Functie | Einde |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Chief Tech/Sci/R&D Officer | 27-02-2009 |
Harbor-UCLA Medical Center
 Harbor-UCLA Medical Center Medical/Nursing ServicesHealth Services Harbor-UCLA Medical Center provides medical practice, education, and research services. The private company is based in Torrance, CA. | Corporate Officer/Principal | 01-01-1998 |
Opleiding van Emil Kakkis
| Pomona College | Undergraduate Degree |
| David Geffen School of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Harbor-UCLA Medical Center
Harbor-UCLA Medical Center Medical/Nursing ServicesHealth Services Harbor-UCLA Medical Center provides medical practice, education, and research services. The private company is based in Torrance, CA. | Health Services |
| Emil Kakkis & Jenny Soriano Living Trust | |
Everylife Foundation for Rare Diseases
Everylife Foundation for Rare Diseases Miscellaneous Commercial ServicesCommercial Services EveryLife Foundation for Rare Diseases is a non-profit organization that aims to advance the development of treatment and diagnostic opportunities for rare disease patients through science-driven public policy. The non-profit company is based in Novato, CA and was founded by Emil D. Kakkis. The foundation provides training, education, resources, and opportunities to make patient voices heard, with the belief that activating the patient advocate can change public policy and save lives. | Commercial Services |
| Odylia Therapeutics |
